• Version
  • Download 31
  • File Size 991.63 KB
  • File Count 1
  • Create Date May 20, 2019
  • Last Updated May 20, 2019

Eligibility Criteria Intro 2019

Moderator:

Gwynn Ison, MD; U.S. Food and Drug  Administration

Panel Discussion
Edward Kim, MD; Levine Cancer Institute Performance Status
Elizabeth Garrett-Mayer, PhD; American Society of Clinical Oncology
Harpreet Singh, MD; U.S. Food and Drug Administration Drug Washout/Con Meds
Vishal Bhatnagar, MD; U.S. Food and Drug Administration
Scot Ebbinghaus, MD; Merck Prior Therapies
Wayne Rackoff, MD; to Janssen Research Development Lab Reference Range/Test Intervals
Alexander Spira, MD, PhD; Virginia Cancer Specialists
Abhi Nair, MD; U.S. Food and Drug Administration

Patient Advocate
Everett Dodson; 
Georgetown Lombardi Comprehensive Cancer Center


0 Comments

Leave a Reply

Your email address will not be published. Required fields are marked *